$271 Million is the total value of TRV GP IV, LLC's 4 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2021 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGENTA THERAPEUTICS, INC. | 17 | Q4 2022 | 100.0% |
| FULCRUM THERAPEUTICS, INC. | 17 | Q3 2023 | 25.6% |
| PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 40.6% |
| REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 28.4% |
| TANGO THERAPEUTICS, INC. | 9 | Q3 2023 | 82.1% |
| RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 41.2% |
View TRV GP IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-02-09 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-10 |
View TRV GP IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.